BRCA1/2 associated cancer susceptibility: a clinical overview

Online veröffentlicht: 30. Dez. 2016

Seitenbereich: 16 - 24

Eingereicht: 21. Sept. 2015

Akzeptiert: 05. Feb. 2016

DOI: https://doi.org/10.1515/fco-2015-0022

Schlüsselwörter

Brca1, Brca2, Cancer susceptibility, Cancer genetics, Ovarian cancer, Breast cancer, Genetic counseling, Hereditary cancer, Parp inhibitors, Prophylactic surgery, Surveillance

© 2016 De Gruyter Open

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.